Click for best price
Adjuvant Therapy Market Size, Share 2023
Adjuvant therapy is defined as the treatment given in addition to the primary (initial) treatment. In other words it is an additional treatment that is designed to help to reach the ultimate goal.
This report aims to provide a comprehensive presentation of the global market for Adjuvant Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adjuvant Therapy. This report contains market size and forecasts of Adjuvant Therapy in global, including the following market information:
Global Adjuvant Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Adjuvant Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Chemotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adjuvant Therapy include Merck, Bayer, Johnson & Johnson, AstraZenca, Mylan, AbbVie and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adjuvant Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adjuvant Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Adjuvant Therapy Market Segment Percentages, by Type, 2022 (%)
Chemotherapy
Radiotherapy
Hormonotherapy
Others
Global Adjuvant Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Adjuvant Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Medical Institution
Others
Global Adjuvant Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Adjuvant Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adjuvant Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Adjuvant Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Bayer
Johnson & Johnson
AstraZenca
Mylan
AbbVie
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adjuvant Therapy, market overview.
Chapter 2: Global Adjuvant Therapy market size in revenue.
Chapter 3: Detailed analysis of Adjuvant Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adjuvant Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Adjuvant Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Adjuvant Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adjuvant Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adjuvant Therapy Overall Market Size
2.1 Global Adjuvant Therapy Market Size: 2022 VS 2030
2.2 Global Adjuvant Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adjuvant Therapy Players in Global Market
3.2 Top Global Adjuvant Therapy Companies Ranked by Revenue
3.3 Global Adjuvant Therapy Revenue by Companies
3.4 Top 3 and Top 5 Adjuvant Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Adjuvant Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adjuvant Therapy Players in Global Market
3.6.1 List of Global Tier 1 Adjuvant Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Adjuvant Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Adjuvant Therapy Market Size Markets, 2022 & 2030
4.1.2 Chemotherapy
4.1.3 Radiotherapy
4.1.4 Hormonotherapy
4.1.5 Others
4.2 By Type - Global Adjuvant Therapy Revenue & Forecasts
4.2.1 By Type - Global Adjuvant Therapy Revenue, 2018-2023
4.2.2 By Type - Global Adjuvant Therapy Revenue, 2024-2030
4.2.3 By Type - Global Adjuvant Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adjuvant Therapy Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Medical Institution
5.1.4 Others
5.2 By Application - Global Adjuvant Therapy Revenue & Forecasts
5.2.1 By Application - Global Adjuvant Therapy Revenue, 2018-2023
5.2.2 By Application - Global Adjuvant Therapy Revenue, 2024-2030
5.2.3 By Application - Global Adjuvant Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Adjuvant Therapy Market Size, 2022 & 2030
6.2 By Region - Global Adjuvant Therapy Revenue & Forecasts
6.2.1 By Region - Global Adjuvant Therapy Revenue, 2018-2023
6.2.2 By Region - Global Adjuvant Therapy Revenue, 2024-2030
6.2.3 By Region - Global Adjuvant Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Adjuvant Therapy Revenue, 2018-2030
6.3.2 US Adjuvant Therapy Market Size, 2018-2030
6.3.3 Canada Adjuvant Therapy Market Size, 2018-2030
6.3.4 Mexico Adjuvant Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Adjuvant Therapy Revenue, 2018-2030
6.4.2 Germany Adjuvant Therapy Market Size, 2018-2030
6.4.3 France Adjuvant Therapy Market Size, 2018-2030
6.4.4 U.K. Adjuvant Therapy Market Size, 2018-2030
6.4.5 Italy Adjuvant Therapy Market Size, 2018-2030
6.4.6 Russia Adjuvant Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Adjuvant Therapy Market Size, 2018-2030
6.4.8 Benelux Adjuvant Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Adjuvant Therapy Revenue, 2018-2030
6.5.2 China Adjuvant Therapy Market Size, 2018-2030
6.5.3 Japan Adjuvant Therapy Market Size, 2018-2030
6.5.4 South Korea Adjuvant Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Adjuvant Therapy Market Size, 2018-2030
6.5.6 India Adjuvant Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Adjuvant Therapy Revenue, 2018-2030
6.6.2 Brazil Adjuvant Therapy Market Size, 2018-2030
6.6.3 Argentina Adjuvant Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adjuvant Therapy Revenue, 2018-2030
6.7.2 Turkey Adjuvant Therapy Market Size, 2018-2030
6.7.3 Israel Adjuvant Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Adjuvant Therapy Market Size, 2018-2030
6.7.5 UAE Adjuvant Therapy Market Size, 2018-2030
7 Adjuvant Therapy Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Adjuvant Therapy Major Product Offerings
7.1.4 Merck Adjuvant Therapy Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Adjuvant Therapy Major Product Offerings
7.2.4 Bayer Adjuvant Therapy Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Adjuvant Therapy Major Product Offerings
7.3.4 Johnson & Johnson Adjuvant Therapy Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 AstraZenca
7.4.1 AstraZenca Company Summary
7.4.2 AstraZenca Business Overview
7.4.3 AstraZenca Adjuvant Therapy Major Product Offerings
7.4.4 AstraZenca Adjuvant Therapy Revenue in Global Market (2018-2023)
7.4.5 AstraZenca Key News & Latest Developments
7.5 Mylan
7.5.1 Mylan Company Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Adjuvant Therapy Major Product Offerings
7.5.4 Mylan Adjuvant Therapy Revenue in Global Market (2018-2023)
7.5.5 Mylan Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Adjuvant Therapy Major Product Offerings
7.6.4 AbbVie Adjuvant Therapy Revenue in Global Market (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Adjuvant Therapy Major Product Offerings
7.7.4 Novartis Adjuvant Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Adjuvant Therapy Market Opportunities & Trends in Global Market
Table 2. Adjuvant Therapy Market Drivers in Global Market
Table 3. Adjuvant Therapy Market Restraints in Global Market
Table 4. Key Players of Adjuvant Therapy in Global Market
Table 5. Top Adjuvant Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Adjuvant Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Adjuvant Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Adjuvant Therapy Product Type
Table 9. List of Global Tier 1 Adjuvant Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adjuvant Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Adjuvant Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Adjuvant Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Adjuvant Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Adjuvant Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Adjuvant Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Adjuvant Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Adjuvant Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Adjuvant Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Adjuvant Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Adjuvant Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Adjuvant Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Adjuvant Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Adjuvant Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Adjuvant Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Adjuvant Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Adjuvant Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Adjuvant Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Adjuvant Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Adjuvant Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Merck Company Summary
Table 31. Merck Adjuvant Therapy Product Offerings
Table 32. Merck Adjuvant Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Adjuvant Therapy Product Offerings
Table 36. Bayer Adjuvant Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Adjuvant Therapy Product Offerings
Table 40. Johnson & Johnson Adjuvant Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. AstraZenca Company Summary
Table 43. AstraZenca Adjuvant Therapy Product Offerings
Table 44. AstraZenca Adjuvant Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZenca Key News & Latest Developments
Table 46. Mylan Company Summary
Table 47. Mylan Adjuvant Therapy Product Offerings
Table 48. Mylan Adjuvant Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Mylan Key News & Latest Developments
Table 50. AbbVie Company Summary
Table 51. AbbVie Adjuvant Therapy Product Offerings
Table 52. AbbVie Adjuvant Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. AbbVie Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Adjuvant Therapy Product Offerings
Table 56. Novartis Adjuvant Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
List of Figures
Figure 1. Adjuvant Therapy Segment by Type in 2022
Figure 2. Adjuvant Therapy Segment by Application in 2022
Figure 3. Global Adjuvant Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Adjuvant Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Adjuvant Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adjuvant Therapy Revenue in 2022
Figure 8. By Type - Global Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Adjuvant Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Adjuvant Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 16. US Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 28. China Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Adjuvant Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Adjuvant Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Merck Adjuvant Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Adjuvant Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Adjuvant Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZenca Adjuvant Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Mylan Adjuvant Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AbbVie Adjuvant Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Adjuvant Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
